Mental health and HIV medication support for men in low-resource areas
Addressing mental health and HIV medication adherence among high-risk men in a resource-limited setting
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-11383012
This project will try a combined mental-health and medication-support program to help high-risk men in resource-limited areas stay on HIV prevention and treatment.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11383012 on ClinicalTrials.gov |
What this research studies
If you join, researchers will first talk with men like you to shape the program. They'll run a small pilot to refine the counseling and support materials, then test the program in a short randomized comparison against enhanced usual care. Participants will complete interviews and mental-health screens and have medication adherence checked at enrollment, 3 months, and 6 months, including biological adherence measures. The program combines problem-solving therapy, stress-and-coping strategies, and a status-neutral approach so it works for people both on PrEP and on ART.
Who could benefit from this research
Good fit: Ideal participants are men at high risk for HIV or living with HIV in resource-limited settings who are coping with depression or other mental-health challenges and difficulties staying on PrEP or ART.
Not a fit: People who are not men, who live outside the study sites, who already have stable mental health and consistent medication adherence, or who are not eligible for PrEP/ART will likely not benefit directly from participating.
Why it matters
Potential benefit: If successful, the program could improve mental health and increase real medication adherence, lowering the chance of HIV transmission and improving overall health.
How similar studies have performed: Other programs that combine mental-health support with adherence counseling have shown promising results in some groups, but this specific integrated, status-neutral approach for high-risk men in low-resource areas is relatively new.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: OPERARIO, DON — EMORY UNIVERSITY
- Study coordinator: OPERARIO, DON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus